XFORX4 Pharmaceuticals, Inc.May 1, 2025Q1 2025
Read transcript →X4 Pharmaceuticals, Inc. (XFOR) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$3.08
-10.06%
Mkt Cap $337.67M
XFORX4 Pharmaceuticals, Inc.May 1, 2025XFORX4 Pharmaceuticals, Inc.Mar 25, 2025Q4 2024
Read transcript →XFORX4 Pharmaceuticals, Inc.Nov 13, 2024Q3 2024
Read transcript →XFORX4 Pharmaceuticals, Inc.May 7, 2024Q1 2024
Read transcript →XFORX4 Pharmaceuticals, Inc.Mar 21, 2024Q4 2023
Read transcript →XFORX4 Pharmaceuticals, Inc.Nov 9, 2023Q3 2023
Read transcript →XFORX4 Pharmaceuticals, Inc.Aug 10, 2023Q2 2023
Read transcript →XFORX4 Pharmaceuticals, Inc.May 6, 2023Q1 2023
Read transcript →XFORX4 Pharmaceuticals, Inc.Mar 21, 2023Q4 2022
Read transcript →XFORX4 Pharmaceuticals, Inc.Nov 5, 2022Q3 2022
Read transcript →XFORX4 Pharmaceuticals, Inc.Aug 7, 2022Q2 2022
Read transcript →XFORX4 Pharmaceuticals, Inc.May 12, 2022Q1 2022
Read transcript →XFORX4 Pharmaceuticals, Inc.Mar 17, 2022Q4 2021
Read transcript →XFORX4 Pharmaceuticals, Inc.Nov 5, 2021Q3 2021
Read transcript →XFORX4 Pharmaceuticals, Inc.Aug 6, 2021Q2 2021
Read transcript →XFORX4 Pharmaceuticals, Inc.May 9, 2021Q1 2021
Read transcript →XFORX4 Pharmaceuticals, Inc.Mar 4, 2021Q4 2020
Read transcript →XFORX4 Pharmaceuticals, Inc.Nov 7, 2020Q3 2020
Read transcript →XFORX4 Pharmaceuticals, Inc.Aug 2, 2020Q2 2020
Read transcript →XFORX4 Pharmaceuticals, Inc.May 9, 2020Q1 2020
Read transcript →XFORX4 Pharmaceuticals, Inc.Mar 12, 2020Q4 2019
Read transcript →XFORX4 Pharmaceuticals, Inc.Nov 10, 2019Q3 2019
Read transcript →